By Josh Beckerman
Autonomix Medical shares fell to their lowest point yet after the medical device company reported the pricing of a $9 million public offering.
The stock was recently down 53% to $6.31, with an intraday low of $5.85. Adjusted for an October reverse stock split, the company's January initial public offering priced at $100.
The company said Friday that the offering is comprised of 1.38 million common stock units, or pre-funded warrant units in lieu of common stock units, priced at $6.54 per common stock unit or $6.539 per pre-funded warrant unit. The units each have one share or pre-funded warrant plus one Series A warrant.
On Nov. 1, Autonomix filed to offer up to 698,812 common stock units.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
November 22, 2024 13:26 ET (18:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。